In order to localise neuroendocrine tumours of the foregut type (that is, of the stomach, duodenum, and pancreas), 18 patients were studied prospectively by endoscopic ultrasonography, computed tomography, transabdominal ultrasonography, magnetic resonance imaging, and somatostatin receptor scintigraphy. These 18 patients had a total of 25 primary tumour lesions which were verified histologically in tissue obtained by surgery or by ultrasound or endoscopy guided biopsy.
Tumours were found in the stomach (n=-), duodenum (n=6), pancreas (n=17), and liver (n=l) . Endoscopic ultrasonography had the highest sensitivity for tumour detection, followed by somatostatin receptor scintigraphy, computed tomography, transabdominal ultrasonography, and magnetic resonance imaging (88%, 52%, 36%, 32%, and 24% respectively). Endoscopic ultrasonography was especially sensitive in tumours smaller than 2 cm in diameter (88% v somatostatin receptor scintigraphy 35%; computed tomography 12%; transabdominal ultrasonography 6%; and magnetic resonance imaging 0%). Of 17 tumours located in the pancreas, endoscopic ultrasonography showed a sensitivity of 94% (somatostatin receptor scintigraphy 47%; computed tomography 47%; transabdominal ultrasonography 41%; and magnetic resonance imaging 29%). Of eight extrapancreatic tumours, six were identified by endoscopic ultrasonography, five by somatostatin receptor scintigraphy, and only one by computed tomography, transabdominal ultrasonography, and magnetic resonance imaging. One neuroendocrine tumour that was not detected by endoscopic ultrasonography was correctly identified by somatostatin receptor scintigraphy. Endoscopic ultrasound allowed correct determination ofthe tumour size and tumour spread into parapancreatic structures, especially the large vessels (T stage), in all 14 patients operated upon. The lymph node stage (N stage) was correctly determined in 10 of these 14 patients. In summary, endoscopic ultrasonography and somatostatin receptor scintigraphy were the most sensitive imaging methods for the localisation of these tumours and should be used as early diagnostic pro about 400 ml of water were necessary to provide a fluid interface between the transducer and gastrointestinal wall.
Transabdominal US was performed with a Picker LSC 7000 scanner, using a 3-5 MHz and, if necessary, a 5 MHz mechanical sector scanner.
CT scanning was performed with a Siemens DRG scanner, before and after intravenous and oral administration of contrast material. The total abdomen was scanned in 8 mm sections. In addition, the pancreatic region was scanned in 4 mm sections. All images were obtained in transaxial plane.
MRI (Table II) . Of the eight tumours localised in the duodenum, stomach, and liver, endoscopic US detected six (75%) and SRS five (62%), whereas CT, US, and MRI were able to detect only one (12%), a tumour that was localised in the liver and turned out to be a gastrinoma of the liver (Table II) .
The tumours undetected by endoscopic US were: (1) A non-functional tumour of the duodenal wall, 2 mm in size;
(2) An insulinoma of the pancreatic tail, 8 mm in diameter, and; (3) A 3 cm gastrinoma of the lower part of duodenal wall that could not be reached with the echoendoscope. This tumour could be visualised by SRS.
Endoscopic US localised seven of eight insulinomas (87%), four of five gastrinomas (80%), the single carcinoid (100%), and 10 of 11 non-functional tumours (91%) ( Table III) .
SRS localised one of eight insulinomas (12.5%), five of five gastrinomas (100%), the single carcinoid tumour (100%), and six of 11 non-functional tumours (54%) ( Table III) .
Neuroendocrine tumours not detected by planar images were not found by SPECT either. As shown in Table II , neuroendocrine tumours less than 2 cm in diameter could only be identified by endoscopic US and also, in part, by SRS.
In contrast, only one of 17 tumours smaller than 2 cm in diameter, could be detected by conventional imaging methods. CT, US, and MRI were unable to detect any of the seven tumours in the stomach and duodenal wall. Small insulinomas and non-functional tumours were also hardly detected by conventional methods (Table III) .
Endosconographic determination of tumour size, T stage (especially tumour spread into large vessels), and N stage could be directly compared in 14 patients who were operated on consecutively. At surgery, 15 tumours were found in the pancreas, one in the papilla minor, three in the duodenum, one in the stomach, and one in the liver (Table I) . Endoscopic US predicted correctly the T stage in all cases and the N stage in 10 of 14 patients (Table IV) . There were three false positive findings, and one false negative finding, however, with regard to the former, in one patient an adenoma of the left adrenal gland was falsely interpreted by endoscopic US as an infiltrated lymph node. In two other cases, only enlarged lymph nodes without malignant cell infiltration were found. In the case of the false negative, malignant lymph nodes were found in the area of the ligament of Treitz at surgery, but were not detected by endoscopic US.
In 11 of these patients, angiography was carried out preoperatively to determine the tumour vascularisation and spread into large vessels. In eight cases, the tumour location was correctly identified by angiography. A possible vascular infiltration was correctly detected in 10 of 11 cases studied by angiography (Table IV) .
The ultrasonographic features of the tumours studied, were variable and did not differ between functional and non-functional neuroendocrine tumours (Table V) . In addition, tumours that caused a similar hormonal syndrome, for example, insulinomas, showed different ultrasonographic patterns within this tumour subtype (Fig 1 (A) and (B) ). Most tumours showed poor SRS was shown to be a simple and sensitive method for imaging neuroendocrine tumours in the upper gastrointestinal tract. Compared with previous data, however, the sensitivity for the identification of these tumours was lower in this study.'819 This is probably because relatively small tumours were evaluated and only tumours ofthe foregut type were studied. Tumours ofthe foregut more often yield negative results by SRS midgut tumours.26 In comparison with abdominal US, CT, MRI, and endoscopic US, the sensitivity of SRS was independent of the localisation of the tumours but dependent on their functional state (insulinomas<non-functional tumours<gastrinomas) and size (Tables II and  III) .
In summary, low sensitivities of US, CT, and MRI for the detection of gastroenteropancreatic neuroendocrine tumours are observed. We show, furthermore, that tumours less than 2 cm in diameter, and especially those located in the gastrointestinal wall, are rarely visualised by conventional methods but are detected by endoscopic US and, in part, by SRS. For the detection and staging of gastrinomas especially, the combination of SRS and endoscopic US gives a very high accuracy in localising tumours within the pancreas and duodenal and gastric walls. In addition, it represents a sensitive method of identifying lymph nodes and blood vessels infiltrated by tumour tissue.
We conclude that endoscopic US and SRS are the most sensitive imaging methods for gastroenteropancreatic neuroendocrine tumours and should therefore be used early to determine the primary tumours as well as the local spread, especially infiltration of large vessels and involvement of regional lymph nodes.
